1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-Sence and Anti-Gene
1.2.3 Short Inhibitory Sequences
1.2.4 Gene Transfer Therapy
1.2.5 Nucleoside Analogs
1.2.6 Ribozymes
1.2.7 Aptamers
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Academic and Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Based Gene Therapy Market Perspective (2017-2028)
2.2 Nucleic Acid Based Gene Therapy Growth Trends by Region
2.2.1 Nucleic Acid Based Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nucleic Acid Based Gene Therapy Historic Market Size by Region (2017-2022)
2.2.3 Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2023-2028)
2.3 Nucleic Acid Based Gene Therapy Market Dynamics
2.3.1 Nucleic Acid Based Gene Therapy Industry Trends
2.3.2 Nucleic Acid Based Gene Therapy Market Drivers
2.3.3 Nucleic Acid Based Gene Therapy Market Challenges
2.3.4 Nucleic Acid Based Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Based Gene Therapy Players by Revenue
3.1.1 Global Top Nucleic Acid Based Gene Therapy Players by Revenue (2017-2022)
3.1.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Based Gene Therapy Revenue
3.4 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio
3.4.1 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Based Gene Therapy Revenue in 2021
3.5 Nucleic Acid Based Gene Therapy Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Based Gene Therapy Product Solution and Service
3.7 Date of Enter into Nucleic Acid Based Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Based Gene Therapy Breakdown Data by Type
4.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Type (2017-2022)
4.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2023-2028)
5 Nucleic Acid Based Gene Therapy Breakdown Data by Application
5.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Application (2017-2022)
5.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nucleic Acid Based Gene Therapy Market Size (2017-2028)
6.2 North America Nucleic Acid Based Gene Therapy Market Size by Type
6.2.1 North America Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
6.2.2 North America Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
6.2.3 North America Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
6.3 North America Nucleic Acid Based Gene Therapy Market Size by Application
6.3.1 North America Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
6.3.2 North America Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
6.3.3 North America Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
6.4 North America Nucleic Acid Based Gene Therapy Market Size by Country
6.4.1 North America Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
6.4.2 North America Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nucleic Acid Based Gene Therapy Market Size (2017-2028)
7.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type
7.2.1 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
7.2.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
7.2.3 Europe Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
7.3 Europe Nucleic Acid Based Gene Therapy Market Size by Application
7.3.1 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
7.3.2 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
7.3.3 Europe Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
7.4 Europe Nucleic Acid Based Gene Therapy Market Size by Country
7.4.1 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
7.4.2 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (2017-2028)
8.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Type
8.2.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Application
8.3.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region
8.4.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nucleic Acid Based Gene Therapy Market Size (2017-2028)
9.2 Latin America Nucleic Acid Based Gene Therapy Market Size by Type
9.2.1 Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
9.3 Latin America Nucleic Acid Based Gene Therapy Market Size by Application
9.3.1 Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
9.4 Latin America Nucleic Acid Based Gene Therapy Market Size by Country
9.4.1 Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size (2017-2028)
10.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type
10.2.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application
10.3.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country
10.4.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Details
11.1.2 Wave Life Sciences Business Overview
11.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Introduction
11.1.4 Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.1.5 Wave Life Sciences Recent Developments
11.2 Imugene
11.2.1 Imugene Company Details
11.2.2 Imugene Business Overview
11.2.3 Imugene Nucleic Acid Based Gene Therapy Introduction
11.2.4 Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.2.5 Imugene Recent Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Details
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.3.4 Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.3.5 Sarepta Therapeutics Recent Developments
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Details
11.4.2 Alnylam Pharmaceuticals Business Overview
11.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.4.4 Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.4.5 Alnylam Pharmaceuticals Recent Developments
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Details
11.5.2 Ionis Pharmaceuticals Business Overview
11.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.5.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.5.5 Ionis Pharmaceuticals Recent Developments
11.6 Moderna
11.6.1 Moderna Company Details
11.6.2 Moderna Business Overview
11.6.3 Moderna Nucleic Acid Based Gene Therapy Introduction
11.6.4 Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.6.5 Moderna Recent Developments
11.7 BioNTech
11.7.1 BioNTech Company Details
11.7.2 BioNTech Business Overview
11.7.3 BioNTech Nucleic Acid Based Gene Therapy Introduction
11.7.4 BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.7.5 BioNTech Recent Developments
11.8 Nutcracker Therapeutics
11.8.1 Nutcracker Therapeutics Company Details
11.8.2 Nutcracker Therapeutics Business Overview
11.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.8.4 Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.8.5 Nutcracker Therapeutics Recent Developments
11.9 Deep Genomics
11.9.1 Deep Genomics Company Details
11.9.2 Deep Genomics Business Overview
11.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Introduction
11.9.4 Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.9.5 Deep Genomics Recent Developments
11.10 Sirnaomics
11.10.1 Sirnaomics Company Details
11.10.2 Sirnaomics Business Overview
11.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Introduction
11.10.4 Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.10.5 Sirnaomics Recent Developments
11.11 Laronde
11.11.1 Laronde Company Details
11.11.2 Laronde Business Overview
11.11.3 Laronde Nucleic Acid Based Gene Therapy Introduction
11.11.4 Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.11.5 Laronde Recent Developments
11.12 Abogen Biosciences
11.12.1 Abogen Biosciences Company Details
11.12.2 Abogen Biosciences Business Overview
11.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Introduction
11.12.4 Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.12.5 Abogen Biosciences Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer